Search

Displaying results 3691 - 3700 of 7284 in total
  1. Drug

    Mespirenone

    go.drugbank.com/drugs/DB20625
    Experimental

    Mespirenone has a monoisotopic molecular weight of 426.19 Da. … Mespirenone is a small molecule drug. The usage of the INN stem '-renone' in the name indicates that Mespirenone is a mineralocorticoid receptor (MR, MCR, aldosterone receptor) antagonist.

  2. Drug

    Bucainide

    go.drugbank.com/drugs/DB20650
    Experimental

    Bucainide has a monoisotopic molecular weight of 329.28 Da. … Bucainide is a small molecule drug. The usage of the INN stem '-cain-' in the name indicates that Bucainide is a class I antiarrhythmic, procainamide and lidocaine derivative.

  3. Drug

    Propyperone

    go.drugbank.com/drugs/DB20765
    Experimental

    Propyperone has a monoisotopic molecular weight of 388.25 Da. … Propyperone is a small molecule drug. The usage of the INN stem '-perone' in the name indicates that Propyperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.

  4. Drug

    Carperone

    go.drugbank.com/drugs/DB21088
    Experimental

    Carperone has a monoisotopic molecular weight of 350.2 Da. … Carperone is a small molecule drug. The usage of the INN stem '-perone' in the name indicates that Carperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.

  5. Drug

    Pentamustine

    go.drugbank.com/drugs/DB21291
    Experimental

    Pentamustine has a monoisotopic molecular weight of 221.09 Da. … Pentamustine is a small molecule drug. The usage of the INN stem '-mustine' in the name indicates that Pentamustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative.

  6. Drug

    Izilendustat

    go.drugbank.com/drugs/DB21532
    Experimental

    Izilendustat has a monoisotopic molecular weight of 433.18 Da. … Izilendustat is a small molecule drug. The usage of the INN stem '-dustat' in the name indicates that Izilendustat is a hypoxia inducible factor (HIF) prolyl hydroxylase inhibitor.

  7. Drug

    Civorebrutinib

    go.drugbank.com/drugs/DB21641
    Experimental

    Civorebrutinib has a monoisotopic molecular weight of 463.15 Da. … Civorebrutinib is a small molecule drug. The usage of the INN stem '-brutinib' in the name indicates that Civorebrutinib is a agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitor.

  8. Drug

    Chloroquine

    go.drugbank.com/drugs/DB00608
    ApprovedInvestigationalVet approved

    [L14312]** Chloroquine was granted FDA Approval on 31 October 1949.[L12054] … [A192432] **The FDA emergency use authorization for [hydroxychloroquine] and chloroquine in the treatment of COVID-19 was revoked on 15 June 2020.

  9. Drug

    Inebilizumab

    go.drugbank.com/drugs/DB12530
    ApprovedInvestigational

    Compared to the anti-CD20 antibody [rituximab], which is also used to treat NMOSD, inebilizumab has broader specificity. … [L49861] In April 2025, inebilizumab was additionally approved by the FDA for immunoglobulin G4-related disease (IgG4-RD).[L52705,L14315] It is the first and only FDA-approved treatment for IgG4-RD.

  10. Drug

    Andexanet alfa

    go.drugbank.com/drugs/DB14562
    Approved

    Andexanet alfa is currently under regulatory review by the European Union and is undergoing clinical development in Japan [A35518]. … assemble the prothrombinase complex [A35558].